Deferred Tax Assets, Valuation Allowance of Q32 Bio Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Q32 Bio Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Q32 Bio Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $98,471,000, a 7.9% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Q32 Bio Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $98,471,000 -$8,405,000 -7.9% 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q4 2024 $106,876,000 +$51,798,000 +94% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q4 2023 $55,078,000 -$124,574,000 -69% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q4 2022 $179,652,000 +$16,258,000 +10% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q4 2021 $163,394,000 +$38,360,000 +31% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q4 2020 $125,034,000 +$47,241,000 +61% 31 Dec 2020 10-K 23 Mar 2022 2021 FY
Q4 2019 $77,793,000 +$40,173,000 +107% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q4 2018 $37,620,000 +$25,132,000 +201% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q4 2017 $12,488,000 31 Dec 2017 10-K 12 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.